Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

NCT00165815 ·Status: COMPLETED ·Phase: PHASE3

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

NCT00711204 ·Status: WITHDRAWN ·Phase: PHASE4

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375 ·Status: COMPLETED ·Phase: PHASE4

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

NCT00103948 ·Status: COMPLETED ·Phase: PHASE2

Non-Interventional Study With Aricept® Evess

NCT00889603 ·Status: COMPLETED

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

NCT01260948 ·Status: COMPLETED ·Phase: PHASE1

Drug-Drug Interaction Study With Aricept® (Donepezil)

NCT01042314 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Comparisons of Two Donepezil Formulations

NCT01297036 ·Status: COMPLETED ·Phase: PHASE1

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

NCT02262975 ·Status: COMPLETED

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

NCT01260922 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia

NCT01327859 ·Status: COMPLETED ·Phase: PHASE3

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

NCT00467766 ·Status: COMPLETED ·Phase: NA

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

NCT02158910 ·Status: COMPLETED

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

NCT02448784 ·Status: COMPLETED

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00230568 ·Status: COMPLETED ·Phase: PHASE4

Intensive Instruction on the Use of Aricept

NCT01972204 ·Status: COMPLETED ·Phase: NA

Neural Correlates In Mild Alzheimer's Disease

NCT00477659 ·Status: COMPLETED ·Phase: PHASE4

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

NCT00478205 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

NCT00911807 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

NCT02822573 ·Status: COMPLETED ·Phase: PHASE3

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

NCT00987220 ·Status: COMPLETED

Effect of Donepezil on Smoking

NCT01250977 ·Status: COMPLETED ·Phase: PHASE2

Memory and Mental Health in Aging

NCT00043589 ·Status: COMPLETED ·Phase: NA

Memory Impairment Study (Mild Cognitive Impairment Study)

NCT00000173 ·Status: COMPLETED ·Phase: PHASE3

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

NCT01251718 ·Status: COMPLETED